Protein clues may reveal which breast cancers respond to chemo
NCT ID NCT00911911
First seen Apr 17, 2026 · Last updated May 24, 2026 · Updated 8 times
Summary
This study aimed to find protein patterns (proteomic signatures) in tumor samples and blood that could predict how well breast cancer responds to chemotherapy given before surgery. Researchers analyzed samples from 66 women with breast cancer who had not received prior chemotherapy. The goal was to better understand which tumors are likely to shrink with treatment, potentially guiding more personalized care in the future.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Centre Henri Becquerel
Rouen, 76038, France
-
Centre Oscar Lambret
Lille, 59020, France
-
Geroges PIANTA Hospital
Thonon-les-Bains, 74 203, France
-
Hopital Saint Vincent
Lille, 59020, France
-
Intercommunal Hospital
Annemasse, 74 107, France
Conditions
Explore the condition pages connected to this study.